Keybanc Maintains Overweight on American Healthcare REIT, Raises Price Target to $68
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsPrice Target
Keybanc analyst Austin Wurschmidt maintains American Healthcare REIT (NYSE:AHR) with a Overweight and raises the price target from $58 to $68.
Keybanc analyst Austin Wurschmidt maintains American Healthcare REIT (NYSE:AHR) with a Overweight and raises the price target from $58 to $68.